13D/A filed by Sermonix Pharmaceuticals, Inc.
Sermonix Pharmaceuticals, Inc. and 1 other reporting person reported 3,149,470 LONA shares, 25.1% of the class, as of 2026-10-26, in a 13D/A accepted by EDGAR 2026-10-28 19:37:30 UTC.
- Accession
- 0001655566-26-000004
- Filer
- CIK 1655566
- Filed
- 2026-10-28
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- LONA · LeonaBio, Inc.
- Shares
- 3,149,470
- Percent of class
- 25.1%
- Event date
- 2026-10-26
How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.
Read for the filer group Sermonix Pharmaceuticals, Inc..
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Sermonix Pharmaceuticals, Inc. | CO | 0 | 3,149,470 | 0 | 3,149,470 | 3,149,470 | 25.1% |
| Portman David J. | IN | 0 | 3,149,470 | 0 | 3,149,470 | 3,149,470 | 25.1% |